Noul Inc. has developed the next generation POC (Point-Of-Care) blood testing platform for resource-limited medical facilities, clinics, and local hospitals. Noul seeks to solve global challenges that threaten human life, to discover novel solutions, and to establish a new gold standard in POC blood testing. 

Noul’s solution aims to improve accessibility to proper health care by integrating innovations in biology, artificial intelligence, mobile technology, robotics, and software/hardware engineering. 

Noul has filed over 65 global patents, conducted more than seven field clinical trials, and has research partnerships with world-class global institutions.

[Mission]
We explore global challenges that threaten human health and life, discover novel potential solutions, and realize those possibilities.

[Goal]
1. To contribute to eliminating malaria, tb, aids and other neglected diseases through innovative diagnostic platform.
2. To proactively increase healthcare accessibility through next-generation blood diagnostics platform.


AI/ML

Biotechnology

Health Care

Health Diagnostics

Medical Devices

NOUL Co., Ltd.

NOUL Co., Ltd.'s headquarters in Yongin-si, Republic of Korea

David Lim

Jaewon Song

Anny Kwanghee Jung

Th Kim

Youngmin Shin

Jungkwon Ahn

Engineering and Development

Sales and Marketing

Leadership Team

NOUL Co., Ltd.

Org chart

Teams

Engineering and Development

Sales and Marketing

Leadership Team

Offices

Similar companies